Article Sidebar

Published
May 1, 2024
Download
pdf
Statistic
Read Counter : 575 Download : 487

Main Article Content

Abstract

: The research endeavour involved the collection of a total of 100 samples from diverse
clinical origins. Specifically, 70 urine samples were obtained from patients, while 20 samples were
derived from wounds. Additionally, 10 samples were acquired through ear swabs from patients enrolled
in private clinics, Imam Sadiq Hospital, and Al-Hilla Hospitals. The data collection period spanned from
November 2023 to December 2024.
Out of the hundred samples that were analyzed, it was observed that a significant majority, specifically
eighty samples (80%), exhibited positive bacterial cultures. Conversely, a smaller proportion of the
samples, precisely twenty samples (20%), did not exhibit any growth of bacteria. The findings of this
study indicate the potential existence of microorganisms, including viruses, fungi, and other anaerobic
agents, which could pose challenges in terms of culturing or may be attributed to variations in the sizes
and compositions of the samples. Utilizing the Vitek 2 methodology, selective media, and biochemical
assays, it was observed that out of the eighty-nine samples analyzed, a subset of twenty samples
exhibited positive outcomes, suggesting Proteus mirabilis presence. The detection of luxS, rsmA, and
mrpA genes in Proteus mirabilis was accomplished using the polymerase chain reaction (PCR)
technique.

Keywords

Proteus mirabilis lux s rsm A and mrp A genes detection Vitek 2 system

Article Details

License

Copyright (c) 2024 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. Bonnin RA, Girlich D, Jousset AB, Gauthier L, Cuzon G, Bogaerts P et al (2020) A single Proteus mirabilis
  2. lineage from human and animal sources: a hidden reservoir of OXA-23 or OXA-58 carbapenemases in
  3. Enterobacterales. Sci Rep 10(1):1–9. https://doi.org/10.1038/s41598-020-66161-z.
  4. Li Z, Peng C, Zhang G, Shen Y, Zhang Y, Liu C et al (2022) Prevalence and characteristics of
  5. multidrug-resistant Proteus mirabilis from broiler farms in Shandong Province, China. Poult Sci
  6. (4):101710. https://doi.org/10.1016/j.psj.2022.101710.
  7. Hasan TH, Alasedi KK, Jaloob AA (2021) Proteus mirabilis virulence factors. Int J Pharm Res 13(1):2145–
  8. https://doi.org/10.31838/ijpr/2021.13.01.169.
  9. Yuan F, Huang Z, Yang T, Wang G, Li P, Yang B et al (2021) Pathogenesis of Proteus mirabilis in catheterassociated urinary tract infections. Urol Int 105(5-6):354–361. https://doi.org/10.1159/000514097.
  10. Humphries R, Bobenchik AM, Hindler JA, Schuetz AN (2021) Overview of changes to the clinical and
  11. laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. J Clin
  12. Microbiol 59(12):e00213. https://doi.org/10.1128/JCM.00213-21.
  13. Algammal AM, Hashem HR, Alfifi KJ, Hetta HF, Sheraba NS, Ramadan H et al (2021) atpD gene sequencing,
  14. multidrug resistance traits, virulence-determinants, and antimicrobial resistance genes of emerging XDR and
  15. MDR-Proteus mirabilis. Sci Rep 11(1):1–15. https://doi.org/10.1038/s41598-021-88861-w.
  16. Shelenkov A, Petrova L, Fomina V, Zamyatin M, Mikhaylova Y, Akimkin V (2020) Multidrug-resistant
  17. Proteus mirabilis strain with cointegrate plasmid. Microorganisms
  18. (11):1775. https://doi.org/10.3390/microorganisms8111775.
  19. Mirzaei A, Nasr Esfahani B, Raz A, Ghanadian M, Moghim S (2021) From the urinary catheter to the
  20. prevalence of three classes of integrons, β-lactamase genes, and differences in antimicrobial susceptibility of
  21. Proteus mirabilis and clonal relatedness with Rep-PCR. Biomed Res Int
  22. :9952769. https://doi.org/10.1155/2021/9952769.
  23. Critchley IA, Cotroneo N, Pucci MJ, Jain A, Mendes RE (2020) Resistance among urinary tract pathogens
  24. collected in Europe during 2018. J Glob Antimicrob Resist 23:439–
  25. https://doi.org/10.1016/j.jgar.2020.10.020.
  26. Lin M-F, Liou M-L, Kuo C-H, Lin Y-Y, Chen J-Y, Kuo H-Y (2019) Antimicrobial susceptibility and
  27. molecular epidemiology of Proteus mirabilis isolates from three hospitals in Northern Taiwan. Microb Drug
  28. Resist 25(9):1338–1346. https://doi.org/10.1089/mdr.2019.0066.
  29. Filipiak A, Chrapek M, Literacka E, Wawszczak M, Głuszek S, Majchrzak M et al (2020) Pathogenic factors
  30. correlate with antimicrobial resistance among clinical Proteus mirabilis strains. Front Microbiol
  31. :579389. https://doi.org/10.3389/fmicb.2020.579389.
  32. Al-Dulaimi MTS, Al-Taai HRR (2020) Detection of some virulence factors and antibiotics susceptibility of
  33. Proteus mirabilis isolated from different clinical sources in Baquba. Biochem Cell Arch 20(1):803–
  34. https://doi.org/10.35124/bca.2020.20.1.803.
  35. Jaber AH, Almiyah SAF (2022) Molecular detection of some virulence genes for Proteus mirabilis bacteria
  36. isolated from diabetic foot ulcers. Eurasian Med Res Period 8:59–67 ISSN: 2795-7624 (E).
  37. Cahan, E. As Superbugs Flourish, Bacteriophage Therapy Recaptures Researchers' Interest. J. Am. Med.
  38. Assoc. 2023, 329, 781–784. [Google Scholar] [CrossRef] [PubMed].
  39. Al-Nabhani, N. A. and A. M. J. I. j. o. b. Shami (2023). "Molecular Study of Carbapenem Resistance Genes in
  40. Proteus mirabilis Isolated from Clinical Samples in Baghdad Hospitals."v Al- 11.Nabhani, N. A. and A. M. J. I. j.
  41. o. b. Shami (2023). "Molecular Study of Carbapenem Resistance.
  42. Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired
  43. urinary tract infection (CA-UTI) in Brazil. de Oliveira, Wellington Danilo, et al. Microbial Pathogenesis (2021):
  44. Quick Identification and Differentiation of Proteus spp. by PCR and RFLP Along with Their Antibiotic
  45. Resistance Pattern. H Jannat, Samsuzzaman SM. Mymensing medical journal (2021): 355-361.
  46. Preparation and evaluation of liquid fertilizer from Turbinaria ornata and Ulva reticulata. Karthik T, et al.
  47. Biocatalysis and Agricultural Biotechnology (2020): 101712.
  48. Association among biofilm formation, virulence gene expression, and antibiotic resistance in Proteus
  49. mirabilis isolates from diarrhetic animals in Northeast China. Sun, Yadong, et al. BMC Veterinary Research
  50. (2020): 1-10.
  51. Virulence, resistance and clonality of Proteus mirabilis isolated from patients with community-acquired
  52. urinary tract infection (CA-UTI) in Brazil. de Oliveira, Wellington Danilo, et al. Microbial Pathogenesis (2021):
  53. Razzaque, M.S. Commentary: Microbial Resistance Movements: An Overview of Global Public
  54. Health Threats Posed by Antimicrobial Resistance, and How Best to Counter. Front. Public Health 2021, 8, 10–
  55. [Google Scholar] [CrossRef] [PubMed].
  56. of Biofilm Production on Antibiotic Resistance in Proteus mirabilis Isolated from Clinical Samples in Kirkuk
  57. City.

Similar Articles

You may also start an advanced similarity search for this article.